Navigating the complexities of cannabis banking
The cannabis industry is growing at an unprecedented pace, and with it comes exciting opportunities for financial institutions to expand their loan portfolios. Cannabis-related businesses (CRBs)—spanning everything from cultivation to retail—represent a market in need of lending services, from working capital to real estate and equipment loans. Yet, they remain underserved due to the risks involved. Federal regulations under the Controlled Substances Act (CSA) still classify marijuana as a Schedule I substance, along with heroin and methamphetamine. Although most states have legalized marijuana for medicinal or recreational use, the fact remains that it is federally illegal. Many are calling for a re-evaluation of federal laws to better match state legislation.
Most traditional financial institutions are federally insured, and technically, if banks and credit unions provide services to CRBs, they could be criticized for participating in money laundering. With this regulatory risk and associated operational complexities, there is plenty for financial institutions to consider before diving into cannabis lending. With the right approach, the rewards may outweigh the risks, creating opportunities for both financial institutions and the communities they serve.
Now that the cannabis industry is maturing and better understood, is it time for financial institutions to take on that risk? According to FinCEN suspicious activity report (SAR) data, over 800 financial institutions have decided yes, at least to banking deposit services for CRBs. But what about lending?